The CPMC hosts three dedicated working groups: one to address barriers to accessing biomarker and genetic testing for inherited mutations and inherited cancer risk, one to promote best practices in patient education about precision medicine, and another to explore systemic barriers for underserved populations.
Working Groups2026-09-18T20:20:34+00:00
